Navigation Links
HIV-positive Individuals Have a Massively Increased Risk of Osteonecrosis

People with HIV have approximately a hundred times greater risk of developing osteonecrosis (bone death) than the general population,// researchers at the US National Institutes of Health have found. The findings were published in the March 1st online edition of Clinical Infectious Diseases.

Incidence

Osteonecrosis or ‘bone death’ occurs when the blood supply to the bone is disrupted, leading to painful bone decay and loss, usually at the ends of bones such as those in the hip joint. Osteonecrosis of the hip joint usually requires hip replacement surgery.

In the general population, between 0.003 and 0.006 new cases of osteonecrosis are estimated to occur per hundred people, per year. Well-defined studies have not yet been conducted in HIV-positive people, but retrospective case studies have given estimates of 0.03 to 0.37 new cases per hundred per year. The purpose of this National Institutes of Health (NIH) study was to find the rate of new cases of osteonecrosis in a group of HIV-positive patients, and to study the natural history (progression) of the condition.

In 2002, the authors of the current paper reported that 15 (4.4%) of a group of 339 asymptomatic HIV-positive patients (at NIH clinics in Bethesda, Maryland) had osteonecrosis of the hip, confirmed by magnetic resonance imaging (MRI scan). Patients from this study were then enrolled in a prospective follow-up. Two hundred and thirty-nine participants who did not have osteonecrosis in the first study received a second MRI hip screening a median of 23 months after the first, between February 2001 and January 2002. New cases of osteonecrosis were diagnosed in three (1.3%) of these 239 patients – an incidence rate of 0.65 cases per hundred people per year.

Natural history

A follow-up ‘natural history’ study was done on a total of 40 HIV-positive people with osteonecrosis: the fifteen diagnosed in the first study, the th
'"/>




Page: 1 2 3

Related medicine news :

1. HIV-positive Parents Require More Counseling
2. One-year sentence for HIV-positive woman
3. Voices of HIV-positive missing at AIDS conference
4. Risk of Malaria treatment failure in some HIV-positive patients
5. Libyan Lawyers For The HIV-positive Children Seek 15million Dinars As Compensation
6. Five HIV-positive Children Ousted from Kerala School
7. Should HIV-positive Mothers Breast-feed?
8. New Cause of Chronic Liver Disease Identified in HIV-positive Patients
9. Large Study Finds No Need to Screen HIV-positive Patients for Thyroid Disease
10. Depression Increases the Risk of Disease Progression and Death in HIV-positive Women
11. Individuals with sleep related breathing disorders more prone to heart disease
Post Your Comments:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
..., DANBURY, Conn., May 11 The National Organizatio...S. Senator, a top Administration official, a cutti... companies developing treatments for rare diseases...nd others are honored for significant achievements...
..., Kris Jenner receives non-surgical treatment by S...r, entrepreneur, talent manager, socialite, celebr...e Kardashians , will receive the triniti(TM) skin ...he triniti skin treatment is a 3-in-1 non-surgical...
..., Historic Deal Would Save $2 Trillion in Health C...t Momentum to Passing Health Care Reform in Congre...stakeholders in health care reform joined Presiden...eventive care, manage chronic illnesses, curtail u...
...Risk for incorrect but worrying findings rises 50 ... MONDAY, May 11 (HealthDay News) -- The more cance...k of having at least one false-positive result, re... a study in the May/June issue of the Annals of F...
..., HOUSTON, May 11 Carriage Services, Inc. (NYSE: ...ompany & Investment Profile", which can be fou...ervices.com . , , Carriage,s updated Company &am...l outlook and more. , , The Company & Inve...
..., Company to hold Conference Call on May 14, 2009 ...CALS, INC. (OTC Bulletin Board: VION) today annou...09. , , The Company reported a net loss of $4....eriod. Weighted-average common shares outstanding...
Other Medicine News:Health News:NORD to Honor Rare Disease Pioneers 2Health News:NORD to Honor Rare Disease Pioneers 3Health News:triniti(TM) Skin Treatment to be Featured in Keeping Up with The Kardashians Episode 2Health News:Kaine Lauds President Obama's Agreement With Health Care Industry Groups to Reduce Health Care Costs 2Health News:More Cancer Tests Mean More False-Positive Results 2Health News:More Cancer Tests Mean More False-Positive Results 3Health News:Carriage Services Updates Company & Investment Profile 2Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 2Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 3Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 4Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 5
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3Florida Celebrates National Healthcare Quality Week 59698 1Florida Celebrates National Healthcare Quality Week 59698 2ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 1ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 2ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 3ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 4ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 5
...OR, Mich., March 9 Terumo Heart, Inc. today annou...University Medical Center recently became the sec...plant the DuraHeart(TM) Left-Ventricular Assist Sy... U.S. pivotal trial, a multi-center, prospective, ... to 40 centers nationwide. The trial will evaluat...
..., March 6 The American Medical Association (AMA) ...e 2009 Seed Grant Research Program. Established i...cal students, physician residents and fellows to c... projects. This year,s award winners are conducti... , Cardiovascular/pulmonary diseases , ...
Other Medicine Technology:Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient 2Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient 3AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: